Celularity (CELUW) Gains from Investment Securities (2019 - 2025)

Celularity (CELUW) has 7 years of Gains from Investment Securities data on file, last reported at -$2.0 million in Q4 2025.

• Gains from Investment Securities for Q4 2025 came in at -$2.0 million, down 139.13% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.7 million (up 1015.24% YoY), and the FY2025 annual result was $3.8 million, up 1055.78% from the prior year.
• Gains from Investment Securities fell to -$2.0 million in Q4 2025 per CELUW's latest filing, from $4.3 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $104.4 million in Q4 2023 and troughed at -$43.2 million in Q2 2022.
• A 5-year average of $4.9 million and a median of $75500.0 in 2023 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2021 and 2024: Gains from Investment Securities soared 36539.6% in 2021, then slumped 5327.61% in 2024.
• A 5-year view of Gains from Investment Securities shows it stood at -$23.3 million in 2021, then soared by 54.95% to -$10.5 million in 2022, then soared by 1095.05% to $104.4 million in 2023, then slumped by 100.79% to -$828000.0 in 2024, then plunged by 139.13% to -$2.0 million in 2025.
• Business Quant data shows CELUW's Gains from Investment Securities at -$2.0 million in Q4 2025, $4.3 million in Q3 2025, and $1.3 million in Q2 2025.